Related Experiment Video
Updated: Jul 19, 2026

Lumbar Intrathecal Injection of SOD1-ASOs for Precise CNS Targeting and Predictive Efficacy in Human SOD1-G93A ALS Mice
Published on: February 24, 2026
Response of intrathecal baclofen resistance to dose reduction
Joanna A Cooper1, Barbara Ridley
1Spasticity Management Program, Alta Bates Summit Medical Center, Berkeley, CA, USA. Cooperj2@sutterhealth.org
Abstract:
Dose stabilization of intrathecal baclofen (ITB) is usually achieved within 6 to 18 months. In some patients, an increase in ITB dose may result in paradoxical unresponsiveness to baclofen. We present two cases demonstrating increased tone and functional decline with increasing ITB doses after a period of clinical stability. In both cases, reduction of ITB dose was associated with marked clinical improvement.
Related Concept Videos
Desensitization and Tachyphylaxis
Several...
Drug Delivery: Parenteral Route
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
Local Anesthetics: Clinical Application as Spinal Anesthesia
Depolarizing Blockers: Pharmocokinetics
Dose Response Curve: Conventional Versus Nonmonotonic
Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin
The binding of dantrolene to the RYR1...

